Author Archives: Constance Gatbois

Vivet Therapeutics is pleased to join AASLD - The Liver Meeting  in Boston, MA this year.

Meet with Vivet Therapeutics for an update on the GATEWAY gene therapy clinical trial for Wilson disease – booth B908

Excited to kick off ESGCT's 30th Annual Congress in Brussels today!

Join Vivet's New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on the topic "Gene Therapy for Metabolic Diseases" on 25 October at 2:30 pm.